These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 29774531)

  • 1. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ertapenem for the treatment of Hidradenitis suppurativa: how much do we need it?
    Mendes-Bastos P; Martorell A; Magina S
    Actas Dermosifiliogr (Engl Ed); 2018 Sep; 109(7):582-583. PubMed ID: 29803362
    [No Abstract]   [Full Text] [Related]  

  • 3. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin as an indicator of disease activity in severe hidradenitis suppurativa.
    Braunberger TL; Lowes MA; Hamzavi IH
    Int J Dermatol; 2019 Sep; 58(9):1090-1091. PubMed ID: 30094834
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients.
    Join-Lambert O; Coignard-Biehler H; Jais JP; Delage M; Guet-Revillet H; Poirée S; Duchatelet S; Jullien V; Hovnanian A; Lortholary O; Nassif X; Nassif A
    J Antimicrob Chemother; 2016 Feb; 71(2):513-20. PubMed ID: 26565016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA: FOCUS ON ALTERNATIVES.
    Tchernev G
    Georgian Med News; 2023; (340-341):297-300. PubMed ID: 37805915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa- Reply.
    Lyons AB; Parks-Miller A; Zubair R; Hamzavi IH
    Int J Dermatol; 2019 Apr; 58(4):E88. PubMed ID: 30515760
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter to the Editor regarding "Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa".
    Hegde SG; Ravikumar BC
    Int J Dermatol; 2019 Apr; 58(4):E87-E88. PubMed ID: 30246278
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Therapies for Hidradenitis Suppurativa: A Retrospective Chart Review of 31 Patients.
    McPhie ML; Bridgman AC; Kirchhof MG
    J Cutan Med Surg; 2019; 23(3):270-276. PubMed ID: 30658534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa.
    Seyed Jafari SM; Knüsel E; Cazzaniga S; Hunger RE
    Dermatology; 2018; 234(1-2):71-78. PubMed ID: 29758553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.
    Kimball AB; Jemec GB; Yang M; Kageleiry A; Signorovitch JE; Okun MM; Gu Y; Wang K; Mulani P; Sundaram M
    Br J Dermatol; 2014 Dec; 171(6):1434-42. PubMed ID: 25040429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymecycline vs. clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasonography evaluation.
    Caposiena Caro RD; Molinelli E; Brisigotti V; Offidani A; Bianchi L
    Clin Exp Dermatol; 2021 Jan; 46(1):96-102. PubMed ID: 32683727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2017 Jan; 76(1):54-59. PubMed ID: 27692736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.
    Kimball AB; Tzellos T; Calimlim BM; Teixeira HD; Geng Z; Okun MM
    Acta Derm Venereol; 2018 Nov; 98(10):932-937. PubMed ID: 30085324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa.
    Segura Palacios JM; Soto Moreno A; Valladares Millán I; Rivas Ruiz F; Cuenca Barrales C; Molina Leyva A
    J Dermatolog Treat; 2023 Dec; 34(1):2179368. PubMed ID: 36779676
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical outcomes and the impact of major surgery on quality of life, activity impairment and sexual health in hidradenitis suppurativa patients: a prospective single centre study.
    Prens LM; Huizinga J; Janse IC; Horváth B
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1941-1946. PubMed ID: 31132177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective modified conservative tissue preserving protocol to treat stage I axillary hidradenitis suppurativa: a prospective cohort study of 627 patients with five years follow-up.
    Shirah BH; Shirah HA
    J Dermatolog Treat; 2017 Aug; 28(5):458-463. PubMed ID: 27981857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.
    Hessam S; Sand M; Meier NM; Gambichler T; Scholl L; Bechara FG
    J Dermatol Sci; 2016 Nov; 84(2):197-202. PubMed ID: 27554338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.